Ari M. Melnick, MD

For pivotal research demonstrating that transcription factors are druggable targets, characterizing epigenetic landscapes in cancer, identifying novel disease mechanisms such as IDH mutation-induced epigenetic events, and defining novel epigenetic mechanisms responsible for disrupting the immune system and promoting malignant transformation.

*Full-length biography in development

[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]